Total Payments
$2,278
2024 Payments
$1,640
Companies
25
Transactions
120
Medicare Patients
1,052
Medicare Billing
$92,580
Payment Breakdown by Category
Food & Beverage$2,278 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,278 | 120 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $241.44 | 15 | $0 (2024) |
| Novo Nordisk Inc | $231.33 | 12 | $0 (2024) |
| ABBVIE INC. | $229.61 | 15 | $0 (2024) |
| PFIZER INC. | $225.77 | 12 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $194.52 | 5 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $170.80 | 11 | $0 (2024) |
| Exact Sciences Corporation | $159.68 | 5 | $0 (2024) |
| Lilly USA, LLC | $104.16 | 6 | $0 (2024) |
| GlaxoSmithKline, LLC. | $102.93 | 5 | $0 (2024) |
| Amphastar Pharmaceuticals, Inc. | $97.74 | 5 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,640 | 91 | PFIZER INC. ($184.71) |
| 2023 | $522.67 | 21 | AstraZeneca Pharmaceuticals LP ($146.64) |
| 2022 | $31.09 | 2 | ABBVIE INC. ($31.09) |
| 2021 | $31.56 | 2 | AbbVie Inc. ($31.56) |
| 2018 | $40.56 | 3 | Sanofi Pasteur Inc. ($15.49) |
| 2017 | $11.72 | 1 | Exeltis, USA Inc. ($11.72) |
All Payment Transactions
120 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.47 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.98 | General |
| Category: DIABETES | ||||||
| 12/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.26 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $23.51 | General |
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: Inflammation | ||||||
| 11/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.37 | General |
| Category: DIABETES | ||||||
| 11/04/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $20.51 | General |
| 10/30/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.24 | General |
| Category: Bone Health | ||||||
| 10/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.29 | General |
| Category: RESPIRATORY | ||||||
| 10/28/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.40 | General |
| Category: Cardiovascular | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Diabetes | ||||||
| 10/21/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Inflammation | ||||||
| 10/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.81 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: Biological | ||||||
| 10/15/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: Oncology | ||||||
| 10/08/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/02/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.96 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.84 | General |
| Category: DIABETES | ||||||
| 09/25/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 327 | 379 | $59,691 | $29,738 |
| 2022 | 7 | 276 | 380 | $67,085 | $25,286 |
| 2021 | 7 | 228 | 314 | $51,854 | $20,236 |
| 2020 | 7 | 221 | 288 | $48,781 | $17,320 |
Total Patients
1,052
Total Services
1,361
Medicare Billing
$92,580
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 117 | 163 | $30,264 | $15,116 | 49.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 52 | 52 | $13,018 | $6,542 | 50.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 64 | 70 | $10,259 | $3,745 | 36.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 39 | 39 | $3,900 | $2,805 | 71.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,840 | $1,217 | 66.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $410.00 | $313.90 | 76.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 138 | 195 | $29,055 | $11,787 | 40.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 35 | 53 | $11,766 | $4,764 | 40.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $11,000 | $3,311 | 30.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 53 | $9,540 | $2,969 | 31.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 27 | 27 | $4,779 | $1,524 | 31.9% |
| 90682 | Influenza vaccine, quadrivalent derived from recombinant dna | Office | 2022 | 15 | 15 | $645.00 | $635.54 | 98.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 15 | 15 | $300.00 | $295.60 | 98.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 116 | 156 | $23,244 | $10,041 | 43.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 32 | 73 | $13,140 | $4,158 | 31.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $6,500 | $2,063 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 15 | 20 | $4,440 | $1,901 | 42.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 20 | 20 | $3,540 | $1,141 | 32.2% |
| 90682 | Vaccine for influenza derived from dna for injection into muscle, quadrivalent, preservative and antibiotic free | Office | 2021 | 16 | 16 | $670.00 | $670.00 | 100.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 16 | 16 | $320.00 | $262.16 | 81.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 91 | 121 | $17,729 | $6,676 | 37.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 38 | 53 | $11,680 | $3,813 | 32.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 25 | 47 | $8,460 | $2,749 | 32.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 11 | 11 | $5,500 | $1,798 | 32.7% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2020 | 26 | 26 | $4,602 | $1,530 | 33.2% |
About Amanda Carl
Amanda Carl is a Family Medicine healthcare provider based in New Wilmington, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2015. The National Provider Identifier (NPI) number assigned to this provider is 1679952832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Amanda Carl has received a total of $2,278 in payments from pharmaceutical and medical device companies, with $1,640 received in 2024. These payments were reported across 120 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($2,278).
As a Medicare-enrolled provider, Carl has provided services to 1,052 Medicare beneficiaries, totaling 1,361 services with total Medicare billing of $92,580. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location New Wilmington, PA
- Active Since 05/21/2015
- Last Updated 09/16/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1679952832
Products in Payments
- Otezla (Drug) $204.52
- JARDIANCE (Drug) $183.76
- ELIQUIS (Drug) $182.45
- Cologuard Collection Kit (Device) $159.68
- Ozempic (Drug) $141.55
- LYNPARZA (Drug) $121.87
- REXULTI (Drug) $102.51
- MOUNJARO (Drug) $91.20
- Rybelsus (Drug) $89.78
- TRELEGY ELLIPTA (Drug) $86.52
- GEMTESA (Drug) $71.49
- DALVANCE (Drug) $62.65
- FREESTYLE LIBRE 3 (Device) $61.31
- QULIPTA (Drug) $55.30
- LINZESS (Drug) $53.80
- XIFAXAN (Drug) $52.04
- VOQUEZNA (Drug) $50.38
- Auvelity (Drug) $44.69
- PREVNAR 20 (Biological) $43.32
- FARXIGA (Drug) $41.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in New Wilmington
Dr. Anthony Uberti, M.d, M.D
Family Medicine — Payments: $18,677
Family Medicine $18,677
Dr. James Gardner, Md, MD
Family Medicine — Payments: $17,996
Family Medicine $17,996
Kelsey Puskar, Pa-C, PA-C
Family Medicine — Payments: $13,179
Family Medicine $13,179
Kary Schroyer
Family Medicine — Payments: $989.94
Family Medicine $989.94
Margaret Delposen, Md, MD
Family Medicine — Payments: $59.36
Family Medicine $59.36